Purchase Order AG32SCP170480
- Not listed
- Genscript USA Inc., a biotechnology company based in New Jersey, was awarded a $6,463.55 firm fixed-price purchase order contract by the USDA's Northeast Area to generate an IFNAR1 knockout HEK293 cell line. This contract is not set aside for any specific business category. Genscript has a significant blanket purchase agreement (BPA) worth up to $1.5 million with USDA's Animal and Plant Health Inspection Service (APHIS) to provide SARS-CoV-2 surrogate virus neutralization test kits and...
- The U.S. government awarded a $12,411.55 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2021, for animal immunization, cell fusion, subcloning, antibody production, purification, and sequencing services. The contract, which was completed on March 16, 2022, was funded through a civilian federal agency within the Southeast Area and performed at Genscript's facility in Piscataway, New Jersey. No set-aside designation was applied to this award. Genscript USA Inc., a...
- This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...
- This federal contract award, valued at $88,327.43, was issued by the U.S. Department of Agriculture (USDA) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, which is a firm fixed-price purchase order, is for the provision of DNA fragments with 100% guaranteed sequence to support the USDA's Agricultural Research Service (ARS) Plains Area. This award is set aside for small businesses and was made under a solicitation that had a North American Industry...
- The Department of Agriculture Agricultural Research Service Field Research Implementation and Information Delivery awarded a purchase order valued at $24,796.45 to Genscript USA Inc. The contract calls for Genscript to provide custom anti car I 2 monoclonal antibody in support of USDA research efforts. Specifically, the solicitation requested quotes for the antibody meeting associated technical specifications, price breakdowns, and descriptive literature demonstrating compliance. The place of...
- This $8,435.16 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services' National Institutes of Health, to Genscript USA Inc., a for-profit biotechnology company located in Piscataway, New Jersey. The contract is for antibody production services, with a completion date of June 15, 2018. Genscript specializes in providing a range of biomedical research and public health products and services to...
- The U.S. Department of Agriculture's Midwest Area awarded a $3,371.61 firm fixed-price purchase order to Genscript USA Inc. for protein sequencing services on May 18, 2015, with completion targeted for May 31, 2016. The contract, issued without a set-aside designation, leverages Genscript's specialized capabilities in molecular biology and protein production to support federal research initiatives. Performance will be executed at the contractor's facility in Piscataway, New Jersey. Genscript USA...
- This federal contract award to Genscript USA Inc., a biotechnology company based in New Jersey, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,196.16 firm fixed-price purchase order is for gene synthesis services. Genscript, a for-profit organization, has a history of providing a wide range of molecular biology products and services to...
- This federal contract award was made by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $10,470.54 firm fixed price purchase order was awarded on November 1, 2019 with a completion date of October 29, 2020. Genscript provides a wide range of products and services to federal agencies in the areas of biomedical research...
- This $4,448.22 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for custom protein and DNA synthesis services to support biomedical research and public health initiatives. Genscript specializes in providing a range of molecular biology products and services, including gene...
The U.S. Department of Agriculture awarded a $22,817.95 firm fixed-price purchase order to Genscript USA Inc. on September 15, 2017, for Calonectria antibody production based on GenScript Quote #1410287 dated October 10, 2017. The contract, with an ultimate completion date of September 30, 2019, was issued without a set-aside designation. Work will be performed at the contractor's facility in Piscataway, New Jersey. This award supports APHIS' (Animal and Plant Health Inspection Service) research and diagnostic capabilities, contingent upon fund availability. Genscript USA Inc. is a biotechnology company specializing in molecular biology services and antibody development for federal agencies. The company has established a significant contracting presence across multiple federal health and agricultural agencies, including the NIH, CDC, FDA, and USDA, with contract values ranging from approximately $10,000 to over $3 million. Notably, Genscript holds a $1.5 million blanket purchase agreement with USDA APHIS through August 2024 for diagnostic test kits and reagents, demonstrating its critical role in supporting federal research and disease monitoring initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | ($6) | 9/7/19 | |
| 1 | Other Administrative Action | $0 | 8/10/18 | |
| Not listed | Not listed | $22.8k | 9/15/17 |